{
  "items": [
    {
      "title": "Why Organon Is A Top Pick For Income Investors",
      "description": "In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.",
      "published_utc": "2025-03-18T06:58:23",
      "source": "SeekingAlpha",
      "url": "https://finnhub.io/api/news?id=697fea97f771736843602e4ccd567ee09566458d477be611dbdde99159b46b96",
      "category": "company",
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1472143072/image_1472143072.jpg?io=getty-c-w1536",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 133211092,
      "datetime": 1742252303
    },
    {
      "title": "Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider",
      "description": "The latest trading day saw Amgen (AMGN) settling at $317.17, representing a +1.1% change from its previous close.",
      "published_utc": "2025-03-18T06:00:14",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=39a7526e301ae46718f93ca90446d42e78c0cf2243de614387f1f7b888401add",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 133325064,
      "datetime": 1742248814
    },
    {
      "title": "Amgen Inc. stock outperforms competitors on strong trading day",
      "description": "Amgen Inc. stock outperforms competitors on strong trading day",
      "published_utc": "2025-03-18T00:34:00",
      "source": "MarketWatch",
      "url": "https://finnhub.io/api/news?id=b84354278886d46450c4886dc57317fd75b574e723fd3f35db099d58b77c4635",
      "category": "company",
      "image": "",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 133215119,
      "datetime": 1742229240
    },
    {
      "title": "AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study",
      "description": "New late-stage study data shows that treatment with Amgen's Uplizna for a year improves disease symptoms in patients with generalized myasthenia gravis.",
      "published_utc": "2025-03-18T00:05:00",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=9d033066f1282fe2483d1e26fd1f36d59fa00dafcbd8aa32ca43a0dbbfb9afa4",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 133325065,
      "datetime": 1742227500
    },
    {
      "title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
      "description": "Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "published_utc": "2025-03-17T21:00:08",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=bdfeb9beaa5a242e130638f4a41702c3522cf3ec9a72f80abdd96291ccf21bf9",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 133325066,
      "datetime": 1742216408
    }
  ],
  "metadata": {
    "cached_at": "2025-09-25T07:18:52.773880+00:00",
    "cache_key": "news_43af90a65dca713ff79353efe695e92c",
    "count": 5
  }
}